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The DNA topoisomerase found in rat brain neurons relaxes supercoiled DNA in the absence of ATP or 
Mg2+. The estimated content of the active enzyme per nucleus of nerve cell is constant during development 
from a fetal proliferating neuroblast at the embryonic stage of 18 days to the terminally differentiated neu- 
ron (postnatal age of 60 days). The salt stability of DNA topoisomerase association with chromatin varies 
with the stage of development of nerve cells: at 300 mM NaCl most of the enzyme activity (> 90% of the 
removed activity) elutes from differentiated neuron chromatin, whereas only approx. 250/, of the enzyme 
activity elutes from neuroblast chromatin. 
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1. INTRODUCTION 
The topological state of DNA and the enzymes 
that control this state play a crucial role in deter- 
mining the function of DNA in cells. A class of en- 
zymes named DNA topoisomerases promote the 
conversion of one topological isomer into another 
and are considered to regulate the superhelical con- 
formation of DNA within the cell. The DNA 
topoisomerases are widely distributed in different 
cells and mammalian tissues, but not in brain [ 1,2]. 
At the same time, neurons offer the unique 
possibility of studying a single cell type during 
development from a neuroblast, going from the ac- 
tively proliferating precursor cell at late fetal stages 
via a nondividing immature neuron at birth to a 
terminally and permanently differentiated postmi- 
totic neuron thereafter [3]. This development is ac- 
companied by dramatic changes of the neuron 
DNA metabolism. In particular, the DNA poly- 
merase (Y content diminishes correlating tempo- 
rally with the decline of the in vivo rate of mitotic 
activity of neuroblasts, and in mature neurons this 
enzyme is lost completely [4-61. Because of the 
absence of replicative synthesis in neuronal DNA 
coupled with the neuron’s lifetime, which is com- 
parable to that of the organism [7,8], brain DNA 
repair appears to be of prime importance for main- 
taining the functional integrity of a nerve cell 
genome [9- 121. 
Here, we have for the first time found DNA 
topoisomerase in neurons and observed the alter- 
nating salt stability of its association with 
chromatin during differentiation of nerve cells. 
Some properties of this enzyme resemble those of 
type I eukaryotic topoisomerases. 
2. MATERIALS AND METHODS 
2.1. Reagents and determinations 
Polyvinylpyrrolidone 40000 (PVP), phenylmeth- 
ylsulfonyl fluoride (PMSF), poly(dA) and poly- 
(dG) from Sigma were used. Dithiothreitol (DTT) 
and ethidium bromide were obtained from Calbio- 
them, crystalline bovine serum albumin fraction V 
(BSA) from British Drug House, snake venom 
phosphodiesterase from Boehringer-Mannheim, 
poly(ethylene glycol) 6000 (PEG) from Loba 
Chemie, Wien-Fischamend and yeast 8 S RNA 
from Serva. Supercoiled DNA of PM2 phage was 
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isolated and purified according to [ 131. Protein 
concentrations were determined by the technique 
of [ 141. DNA concentration was measured by the 
diphenylamine reaction as modified in [15]. 
2.2. Isolation of neuron nuclei 
Wistar rats of either sex were used. Developmen- 
tal stages included fetuses of 18 days gestation 
(-4-day old animals, since the mean duration of 
gestation in rats is 22 days), as well as animals of 
postnatal ages 14 and 60 days. Cell nuclei were 
isolated from forebrain cortex according to a 
scheme which used intermediate preparation of 
highly purified neuronal cells, the neuronal 
perikarya, which upon gentle disruption yield only 
neuron nuclei [16]. Neuronal perikarya were 
prepared as described [17] with minor modifica- 
tions: (1) the cortex preparations were rinsed in an 
ice-cold standard medium (0.32 M sucrose, 2 mM 
MgC12, 1 mM potassium phosphate, pH 6.5) 
followed by chopping in 7.5% PVP (w/v), 1% 
BSA (w/v) and 10 mM CaC12, and (2) the minced 
brains were filtered through 4 (instead of 3) mesh 
sizes of nylon cloth (705,368, 120 and 65 pm). The 
cell yield decreased in direct proportion with the 
age of the animals [17]. Therefore, for each isola- 
tion different amounts of tissue were taken; 1, 2 
and 100 g from fetuses of 18 days, and from 14- 
and 60-day old animals, respectively, to yield ap- 
prox. 1.2 x 10’ neuron nuclei from animals of each 
indicated developmental stage. The nuclear 
preparations obtained varied in protein/DNA 
weight ratio which increased from 5.3 to 6.9 and 
7.1 during animal development; they contained the 
same amount of DNA, about 7 pg/nucleus. Our 
neuronal preparations were very similar to those 
described by others [16,18,19]. The neuronal 
nuclei were identified as in [16]. The purity of the 
nuclear preparations as to their neuronal origin 
was within 94-97%. 
2.3. Preparation of nuclear extract 
The crude nuclear extract was prepared accor- 
ding to [20], supplementing the isolation medium 
with 0.5 mM PMSF and 0.5 mM DTT. The 
nuclear fractions, isolated as described above from 
fetuses of 18 days and from 14- and 60-day old 
animals, were suspended separately (1 x lo6 nuclei 
of each) in 0.5 ml buffer A (40 mM Tris-HCl (pH 
7.5), 1 mM Na2 EDTA, 0.5 mM PMSF) with 
25 mM NaCl. The nuclei were lysed by slow addi- 
tion, with continuous stirring, of an equal volume 
of buffer A containing 1 mM DTT, 2 M NaCl and 
20% glycerol. The material was sonicated to deter- 
mine the total amount of DNA topoisomerase ac- 
tivity recovered in the chromatin preparation. 
2.4. Chromatin preparation and salt e&ion 
The remaining nuclei of each fraction were 
divided into 5 aliquots (each containing 2 x lo6 
nuclei). The chromatin was isolated under condi- 
tions described in [21]. The resulting crude 
chromatin preparations were resuspended in 
0.5 ml cold buffer A, and an equal volume of the 
same buffer with 1 mM DTT and 20% glycerol 
containing either 0.2, 0.6, 1 .O, 1.6 or 2.0 M NaCl 
was added. The DNA in the chromatin extract was 
precipitated as in [20] by adding 0.5 vol. buffer A 
containing 0.5 mM DTT, 10% glycerol, 18% PEG 
and either 0.1,0.3,0.5,0.8 or 1 .O M NaCl, respec- 
tively. The DNA with the remaining associated 
proteins was removed by centrifugation at 17000 x 
g for 20 min at 4°C and the supernatants aved for 
later assay. 
2.5. Assay of DNA topoisomerase activity 
Topoisomerase relaxation of supercoiled DNA 
was assayed fluorometrically as described [22] 
under nonprocessive reaction conditions at 
170 mM NaCl. This method allows one to exclude 
the influence of interfering deoxyribonuclease ac- 
tivities. 2 ml of the sample with variable amounts 
of enzymic protein in either 0.1, 0.3, 0.5, 0.8 or 
1.0 M NaCl were added to 18 ml of the reaction 
mixture (1 pg of PM2 DNA, 40 mM Tris-HCl 
(pH 7.5), 1 mM NazEDTA and 4 pg BSA) contain- 
ing 160, 140, 120, 90 or 70 mM NaCl, respectively. 
The phosphodiesterase solution was supplemented 
with 1 mM magnesium acetate to protect 
phosphodiesterase from inactivation by EDTA 
[23]. One unit of topoisomerase converts 1 pM of 
PM2 DNA bases to the completely relaxed form in 
10 min at 37°C. 
3. RESULTS 
3.1. Demonstration of DNA topoisomerase 
activity in neuronal nuclei of rat brain 
In the beginning, the extract of neuron nuclei 
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from 16day old rats, was assayed under standard 
(for type I eukaryotic DNA topoisomerase) non- 
processive conditions of supercoiled DNA relaxa- 
tion. This fraction was characterized by a high 
DNA relaxing enzymatic activity which was not 
observed in the absence of monovalent cation. The 
level of relaxing activity was also assayed in 
neuroblasts and differentiated neurons. The DNA 
topoisomerase activity in the nerve cells from rat 
brain of varying age is shown in table 1. The 
specific enzyme activity (in units/mg protein) 
decreased by 30% proportionally with the age of 
the animal from l&day fetuses to 60-day old rats. 
At the same time, the calculations indicate that 
each nucleus contains an equal amount of the en- 
zyme activity due to the increase of protein/DNA 
weight ratio in nuclear preparations during animal 
development, as indicated in section 2.2. 
3.2. Salt elution of the DNA topoisomerase from 
neuronal chromatin 
DNA topoisomerase is known to be associated 
with chromatin [l]. We made an attempt to ex- 
amine the salt dependence of this interaction in 
nerve cells of 18-day fetuses, 14- and 60-day old 
rats. For this purpose the enzyme activity in 
chromatin preparations, obtained as described in 
section 2.4, was assayed. Separate aliquots of the 
isolated chromatin were exposed to various con- 
centrations of NaCl for 10 min and the DNA with 
the remaining associated proteins was removed by 
Table 1 
DNA topoisomerase activity of nerve cell nuclei in 
developing rat brain 
Days of 
development 
Specific activity 
Units/mg protein Units x lo-‘/ 
nucleus 
-4 33.8 r+ 3.9 13.05 * 1.49 
14 27.7 k 2.6 13.46 f 1.69 
60 25.3 + 2.1 12.97 f 1.71 
Fractions were prepared from nerve cells of 18-day 
fetuses (-Cday old rats), 14- and 60-day old rats, as 
described in section 2.3. PM2 DNA relaxation was 
assayed as in section 2.5. The values represent he mean 
of 6 independent determinations 
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PEG precipitation. The enzyme activity eluted 
from chromatin preparation at 1 M NaCl was 
defined as 100% and that at other salt concentra- 
tions is reported relative to 1 M NaCl eluate. 
The salt concentration required to elute the en- 
zyme from chromatin depended strongly on the 
developmental stage of nerve cells (fig.1). For the 
differentiated neuron chromatin at least 90% of 
the activity eluted in 300 mM NaCl, while only 
25% of the activity was removed from neuroblast 
chromatin at this salt concentration. NaCl concen- 
trations of 700 mM or higher were required to 
remove 90% of the activity from the neuroblast 
chromatin (fig. 1A). 
To check for the possible presence of any soluble 
dissociable activator or inhibitor of DNA 
topoisomerase with age we examined the salt elu- 
tion profile of chromatin isolated from a 1 : 1 mix- 
ture of neuroblast and differentiated neuron 
nuclei. We obtained a curve which was in- 
termediate between the two curves shown in 
fig.lA,C (not shown). These results rule against 
the possibility and suggest he identity of the con- 
ditions for different extract preparations. 
Fig. 1. Salt elution profile for DNA topoisomerase from 
nerve cell chromatin in developing rat brain. The 
amount of DNA relaxing activity eluted from chromatin 
extracted from (A) neuroblast (of 1%day fetuses), (B) 
immature neurons (of 1Cday old rats), and (C) 
terminally differentiated neurons (of 60-day old rats), as 
a function of NaCl concentration, was measured as 
described in section 2.5. Each fraction was obtained 
from aliquots of chromatin preparations extracted by 
either 0.1, 0.3, 0.5, 0.8 or 1.0 M NaCl as described in 
section 2.4. The amount of activity found in 1 .O M NaCl 
chromatin extract was 1 x 10m3 units/assay, defined as 
100%. The values represent the mean of 4-6 
determinations from 2 separate experiments. The bars 
indicate the range of values of the determined activity. 
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3.3. Comparative analysis of the enzymes from 4. DISCUSSION 
nerve cell chromatin of 18-day fetuses, 14- 
and 60-day old rats 
One possible explanation for the different salt 
stability for binding of the enzyme to chromatin of 
neuroblasts, immature and differentiated neurons, 
might be a difference in structure of the enzyme 
itself during the process of nerve cell maturation. 
We examined certain enzymatic properties of the 
DNA topoisomerase in fractions obtained as 
described in 2.4 by exposing chromatin to 1 M 
NaCl. In each fraction the optimal Na+ or K+ con- 
centration was 150-200 mM for the relaxing DNA 
topoisomerase activity. At 50 and 250 mM Na+ the 
activities in each fraction were also only 13 and 
35% of the maximal activity, respectively. 
Polynucleotides added to the assay mixture af- 
fected DNA topoisomerase activity of each frac- 
tion in the same manner (table 2). Poly(dG) and 
single-stranded phage X DNA inhibited the enzyme 
(c 10 and < 18% remaining activity, respectively). 
However, the inhibition by poly(dG) is reduced by 
increasing the salt concentration in the assay mix- 
ture. Double-stranded phage X DNA, RNA and 
poly(dA) did not act on the enzyme. 
The results obtained indicate the occurrence of 
DNA topoisomerase in the nerve cell at different 
stages of maturation. This enzyme, like 
topoisomerase I from other sources [1,2], relaxes 
supercoiled DNA in the absence of ATP. In addi- 
tion, it does not require Mg2+ and is active in the 
presence of 1 mM Naz EDTA. The results suggest 
that the DNA topoisomerase from rat brain 
neuron chromatin is an enzyme of type I. It should 
be noted that the most effective inhibition of the 
enzyme was observed with poly(dG) (90070 inhibi- 
tion) but not with poly(dA) (< 10% inhibition). We 
have no satisfactory explanation of this fact. 
However, as reported by authors in [24] calf 
thymus DNA topoisomerase behaves in the same 
manner: it can be selectively inhibited by poly(dG) 
but not by poly(dA), poly(dT) or poly(dC). 
A number of biological functions have been pro- 
posed for type I DNA topoisomerase. It may par- 
ticipate in DNA replication [25], transcription 
[26], recombination [27,28], and repair [29]. The 
postnatal neurons of forebrain are known to have 
no capacity for replicative nuclear DNA synthesis 
related to cell division [7,8]. In nuclei of such 
neurons DNA polymerase fl is virtually the ex- 
clusive representative of this class of enzymes 
[4-61. We have reported a specific exodeox- 
yribonuclease localized in neuronal cell nuclei 
from rat brain which appears to be a DNA repair 
enzyme [12]. We suggest hat one of the major 
functions of DNA topoisomerase in mature 
neurons is also to participate in the repair of DNA 
damage, a process essential for postmitotic cells, 
whose lifetime is comparable to that of the 
organism. We estimate that each nerve cell nucleus 
contains approximately 13 x 10V7 units of 
topoisomerase and this amount is constant during 
the development of animals from the 18-day fetus 
to the 60-day old rat. This ratio is similar to that 
calculated from the data [20,30] for the type I 
topoisomerase from rat liver (approx. 16 x 10e7 
units/nucleus). Thus, the estimated content of 
topoisomerase per nucleus in postmitotic per- 
manently differentiated neurons is similar to that 
in proliferating neuroblasts and also in cells of 
other tissue. 
Table 2 
The effect of polynucleotides on relaxation of 
supercoiled PM2 DNA by the nerve cell DNA 
topoisomerase in developing rat brain 
Added polynucleotides Relative activity (To) of 
chromatin fractions 
I II III 
Poly(dA) 90 95 93 
Poly(dG) 8 7 10 
ssDNA (phage A) 18 15 13 
dsDNA (phage h) 97 93 98 
RNA (yeast) 92 91 96 
DNA topoisomerase activity was assayed as described in 
section 2.5 in the presence of 1 Fg of the indicated 
polynucleotides. Fractions I, II and III are 1 M NaCl 
extracts from nerve cell chromatin of 18-day fetuses, 14- 
and 60-day old rats, respectively. The activity without 
additions was approximately 1 x low3 units/assay, 
defined as 100% 
The binding study presented here shows that the 
salt elution profile of endogenous enzyme from 
303 
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~hromatin of neurobIasts and differentiated 
neurons appears similar to the salt elution profile 
of DNA topoisomerase I from chromatin of grow- 
ing and resting cultivated rodent cells [31]. As in 
the case of the DNA topoisomerase I activity of 
mouse 3T3 cell chromatin, more than 70% of the 
activity remains bound to neuroblast chromatin 
(‘growing’ cells) at 300 mM NaCl and 90% of the 
activity elutes from mature neuron chromatin 
(‘resting’ cells) at this salt concentration (fig. 1). It 
appears reasonable to assume that the salt stability 
is a function of cell developmental stages. Support 
for this assumption comes from a recent review 
PI. 
The age-related salt stability of the enzyme 
binding to chromatin of nerve cells cannot be ex- 
plained by a change of the structure of the enzyme 
itself during the process of nerve cell maturation 
since some properties of the enzyme activities in 
fractions from fetuses of 18 days and from 14- and 
60-day old animals are similar, in particular their 
salt dependence. A possible explanation for this 
phenomenon is a change in the structure and bulk 
of proteins mediating the binding of the enzyme 
during nerve cell development. 
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